Skip to main content
Springer Nature Link
Log in

Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Influenza virus infections cause severe illness worldwide. Vaccination reduces the morbidity and mortality of influenza. The efficacy of vaccines varies due to antigenic differences between the circulating influenza strains and the vaccine. Neuraminidase inhibitors are effective for prophylaxis and treatment of influenza infections, and the emergence of drug resistant mutants is an important challenge. Full-length nucleotide and deduced amino acid sequences of the hemagglutinin and neuraminidase genes of three 2009 pandemic influenza A/H1N1 isolates were compared with the vaccine strain and some strains from different countries. Phylogenetic analysis for hemagglutinin and neuraminidase showed they were related to their vaccine strain, with an average of 99.56 and 99.53% sequence identity, respectively. No genetic indication of resistance to neuraminidase inhibitors was found. Although genomic analysis of hemagglutinin and neuraminidase genes of Iranian strains in comparison to the corresponding vaccine strain revealed some mutations, none of these were identified in functionally important receptor-binding sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Hidayatullah TA (2009) Cloning and expression of antigenic sites of Hemagglutinin of Influenza A virus. IJIB 6(3):137–142

    CAS  Google Scholar 

  2. Mpolya EA, Furuse Y, Nukiwa N, Suzuki A, Kamigaki T and Oshitani H (2009) Pandemic (H1N1) 2009 virus viewed from an epidemiological triangle model. JDR l.4(5):356–364

  3. Richarda M, Del′eagea C, Barth′el′emya M, Linb YP, Hay A, Linaa B et al (2008) Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors. J Clin Virol 41:20–24

    Article  CAS  Google Scholar 

  4. Moscona A (2005) Neuraminidase inhibitors for influenza. NEJM 353(13):1363–1373

    Article  PubMed  CAS  Google Scholar 

  5. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA et al (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses. AAC 52(9):3284–3292

    CAS  Google Scholar 

  6. Kilbourne AD (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12(1):9–14

    PubMed  Google Scholar 

  7. Naffakh N, Werf S (2009) An outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microb Infect. doi:10.1016/j.micinf

  8. Donga H, Zhangb Y, Xionga H, Yana A, Dingc G, Chenag Y et al. (2009) Detection of human novel influenza A (H1N1) viruses using multi-fluorescent real-time RT-PCR. Virus Res 47:85–90

    Google Scholar 

  9. WHO (2009) Pandemic (H1N1) 2009 briefing note 17. Public health significance of virus mutation detected in Norway. 20 November. http://www.who.int

  10. WHO (2009) Pandemic (H1N1) 2009, update 75. http://www.who.int

  11. Deem MW, Pan K (2009) The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. PEDS 22(9):543–546

    PubMed  CAS  Google Scholar 

  12. Smith DJ, Lapedes AS, Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME et al (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305(5682):371–376

    Article  PubMed  CAS  Google Scholar 

  13. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95–98

    CAS  Google Scholar 

  14. Van de Peer Y, De Wachter R (1997) Construction of evolutionary distance trees with TREECON for Windows: accounting for variation in nucleotide substitution rate among sites. Comput Applic Biosci 13:227–230

    Google Scholar 

  15. Padlan EA (2009) The pandemic 2009 (H1N1) swine influenza virus is mild compared to the pandemic 1918 (H1N1) virus because of a proline-to-serine substitution in the receptor- binding site of its hemagglutinin: a hypothesis. Med Hypotheses 73(5):770–780. doi:10.1016/j.mehy.2009.09.034

  16. Zambon MC (1999) Epidemiology and pathogenesis of influenza. JAC 44:3–9

    PubMed  CAS  Google Scholar 

  17. Shen, J, Ma1, J, Wang, Q (2009) Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918. PLoS one. 4(11):e7789, 1–10 (http://www.plosone.org)

  18. Helenius A, Aebi M (2004) Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73:1019–1049

    Article  PubMed  CAS  Google Scholar 

  19. Caton AJ, Brownlee GG, Yewdell JW (1982) The antigenic structure of the influenza virus A/PR/8/34 haemagglutinin (H1 subtype). Cell 31:417–427

    Article  PubMed  CAS  Google Scholar 

  20. Racaniello V (2009) The D225G change in 2009 H1N1 influenza virus is not a concern. http://www.virology.ws (24 November)

  21. Tumpey T, Maines T, Van Hoeven N, Glaser L, Solorzano A, Pappas C et al (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315(5812):655–659

    Article  PubMed  CAS  Google Scholar 

  22. Chutinimitkul S, Chieochansin T, Payungporn S, Samransamruajkit R, Hiranras T, Theamboonlers A et al (2007) Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand. Virus Res 132:122–131

    PubMed  Google Scholar 

  23. Dharan NJ, Gubareva LV, Meyer J, Okomo-Adhiambo M, McClinton RC, Marshall SA et al (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301(10):1034–1041

    Article  PubMed  CAS  Google Scholar 

  24. Antiviral use and the risk of drug resistance. Pandemic (H1N1) 2009. Weekly update 66. http://www.who.int/csr/disease/swineflu/notes/h1n1_antiviral_use_20090925/en/index.html

Download references

Acknowledgments

We would like to thank the entire staff of the National Influenza Centre, Tehran. University of Medical Sciences, for helping us with the research.

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Tehran University of Medical Sciences, Tehran, Iran

    Nazanin Zahra Shafiei Jandaghi, Talat Mokhtari Azad, Maryam Naseri, Jila Yavarian & Rakhshandeh Nategh

Authors
  1. Nazanin Zahra Shafiei Jandaghi
    View author publications

    Search author on:PubMed Google Scholar

  2. Talat Mokhtari Azad
    View author publications

    Search author on:PubMed Google Scholar

  3. Maryam Naseri
    View author publications

    Search author on:PubMed Google Scholar

  4. Jila Yavarian
    View author publications

    Search author on:PubMed Google Scholar

  5. Rakhshandeh Nategh
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Talat Mokhtari Azad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jandaghi, N.Z.S., Azad, T.M., Naseri, M. et al. Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses. Arch Virol 155, 717–721 (2010). https://doi.org/10.1007/s00705-010-0629-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-010-0629-9

Keywords